Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Consistent Processing Of IDE Application Inquiries Facilitated By ODE Memo

This article was originally published in The Gray Sheet

Executive Summary

The Center for Devices and Radiological Health is creating a device center database to track inquiries related to investigational device exemption (IDE) application designations

You may also be interested in...



CDRH Medical/Scientific Hiring Is In Partial Limbo, Awaits Approps

CDRH's Office of Device Evaluation began fiscal 2003 with six fewer medical officers and three fewer scientific reviewers than in the previous year, according to the 1ODE's FY 2002 annual report

CDRH Medical/Scientific Hiring Is In Partial Limbo, Awaits Approps

CDRH's Office of Device Evaluation began fiscal 2003 with six fewer medical officers and three fewer scientific reviewers than in the previous year, according to the 1ODE's FY 2002 annual report

RAPS In Brief

FDA's James Dillard: Deputy Director Bram Zuckerman will become acting director of FDA's Division of Cardiovascular and Respiratory Devices Dec. 3. Current DCRD Director James Dillard departs Nov. 30 for the private sector, where he has accepted the position of VP-science and technology at U.S. Tobacco. Dillard, a fourteen-year FDA veteran, has held the DCRD position for the last 18 months and overseen the reorganization of the division (1"The Gray Sheet" July 24, 2000, p. 10)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015638

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel